1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 1(8)F-FDG PET/CT for post-treatment surveillance imaging of patients with stage III Merkel cell carcinoma
    Journal Article

    Mahajan, S.; Barker, C. A.; Mauguen, A.; D’Angelo, S. P.; Yeh, R.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • PD-L1 expression and overall survival in Asian and western patients with gastric cancer
    Journal Article

    Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C. A.; Tang, L. H.; Zhou, W.; Wu, T.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • The role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; De La Torre, S.; Janjigian, Y. Y.; Maron, S. B.; Ku, G. Y.; Tang, L. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Central diabetes insipidus induced by acute myeloid leukemia with DNMT3A mutation
    Journal Article

    Lakshmanan, P.; Asnani, H.; Knorr, D.
    Case Reports in Endocrinology (2022)

    Fulltext@MSK | Save
  • The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation
    Journal Article

    Ladewig, E.; Michelini, F.; Jhaveri, K.; Castel, P.; Carmona, J.; Fairchild, L.; Zuniga, A. G.; Arruabarrena-Aristorena, A.; Cocco, E.; Blawski, R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML
    Journal Article

    Murdock, H. M.; Kim, H. T.; Denlinger, N.; Vachhani, P.; Hambley, B.; Manning, B. S.; Gier, S.; Cho, C.; Tsai, H. K.; McCurdy, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Wang, M.; Shah, N.; Alencar, A.; Gerson, J.; Patel, M.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A.; Whittaker, S.; Horwitz, S.; Bagot, M.; Huen, A.; Fisher, D.; Haun, P.; Vermeer, M.; Ito, T.; Dwyer, K.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Exploratory analysis: Potential of pelabresib (CPI-0610), a bromodomain and extra-terminal domain inhibitor, as suggested by analysis of improvements in bone marrow histology and function in patients with myelofibrosis-preliminary data
    Meeting Abstract

    Harrison, C.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R.; Vannucchi, A. M.; Rampal, R. K.; Oh, S.; Olteanu, H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Subcutaneous epcoritamab in combination with rituximab and lenalidomide in relapsed or refractory follicular lymphoma: Preliminary phase 1/2 results
    Meeting Abstract

    Linton, K. M.; Wahlin, B.; Leppä, S.; Morschhauser, F.; Elliott, B.; Liu, T.; Stirner, M. C.; Abbas, A.; Falchi, L.
    British Journal of Haematology (2022)

    Fulltext@MSK | Save